DASHTrial

World Stroke Day - Sunday 29th October 2023 “Together we are #Greater Than Stroke” @DashTrial @maps2trial @PhEAST_Trial @Recast3Trial @UoN_STU @tich3trial @ENOS2Trial @MACE_ICH_Trial #stroke #nhs #nottingham

Thread 1/2 @tich3trial NEWSLETTER!! and first one distributed on Twitter. Please retweet 🙏🏼 #stroke #strokeresearch #clinicaltrial #NHS #ICH #tich3

Desmopressin as a potential treatment for stroke due to intracerebral haemorrhage in people taking antiplatelet drugs. Find out the DASH trial results here: dash-1.ac.uk This includes the publication, results video, infographic & lay summary. Thanks to all involved!

The Spring 2023 issue of the ENOS-2 newsflash is available via the documents page. stroke.nottingham.ac.uk/enos-2/docs/pu…

Fantastic work from the team at @UoN_StrokeRes for recruiting their 8th participant into the PhEAST trial today! #STUNottingham #PhEASTTrial

The 2nd issue of the ENOS-2 newsflash is available via the documents page! stroke.nottingham.ac.uk/enos-2/docs/pu… See page 1 below. (1/2)

Everyone from the STU, Nottingham would like to send our sincerest thanks to our sites for all your hard work and support of our Stroke Trials during 2022. We hope you all have a relaxing and enjoyable Christmas and look forward to continue working with you in 2023!

The results of the DASH trial will be presented at UKSF this afternoon (14:10-14:20 in Hall 1A). We hope you will be able to join us! #UKSF22 #NottinghamSTU @UoN_STU @PhEAST_Trial @maps2trial @Recast3Trial @ENOS2Trial @tich3trial

It’s our final day at UKSF! Come and visit us at stand C54! #UKSF22 #NottinghamSTU

Come see us at UKSF stand C54! @PhEAST_Trial @UoN_STU @maps2trial @Recast3Trial @DashTrial @enostrial

Less than a week to go, we hope to see lots of you there! #UKSF22 #NottinghamSTU

Ahead of #WorldStrokeDay, we thank all participants and staff for their collaboration in clinical trials and hopefully together we will find better treatment for stroke nottingham.ac.uk/research/group… @PhEAST_Trial @maps2trial @Recast3Trial @tich3trial @ENOS2Trial #stroke

We hope you will be able to join us at UK Stroke Forum 2022. Investigator meeting and stand details below! #NottinghamSTU

We’re at #ICTMC2022 in Harrogate Convention Centre if you would like to visit us at poster board P-204!

Recruitment has officially closed! With 54 patients being recruited into the trial, exceeding the original target of 50. Thank you to all our sites involved in the trial @NikolaSprigg @mike_desborough

CALLING ALL ATTENDING THE UKSF: Join our CIs on 2nd Dec who will be discussing our 4 newly funded trials here at UoN Stroke Trials Unit and our ongoing trial DASH.

TICH-3 (Tranexamic acid for IntraCerebral Haemorrhage 3): TICH-3 seeks to assess the clinical effectiveness of tranexamic acid (TXA) after intracerebral haemorrhage, and determine whether TXA should be used in clinical practice. stroke.nottingham.ac.uk/tich-3/

MAPS-2 (Metoclopramide for Avoiding Pneumonia after Stroke 2): MAPS-2 is a single-blind, randomised controlled trial of metoclopramide for the prevention of pneumonia in patients with dysphagia after an acute stroke. stroke.nottingham.ac.uk/maps-2/

On #WorldStrokeDay we are highlighting the importance of knowing the signs of stroke and seeking emergency medical care. Face drooping, arm weakness, speech difficulty means time to get emergency medical help. Every second counts, save brain cells, save #Precioustime

When someone has a stroke, every second is crucial. Remember to think F.A.S.T. #WorldStrokeDay #thinkfast #StrokeAwareness